VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HRHealthcare Realty Trust Incorporated
$20.50$7.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHRFinancials

Healthcare Realty Trust Incorporated (HR) Financials

30Y historyFree accessUpdated daily

Revenue growth remains under pressure with a 10.5% year-over-year decline in 2026Q1, while the company reported negative Net Operating Income for seven consecutive quarters through 2025Q4.

HR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.15B1.18B1.27B1.34B932.64M534.82M735.07M693.63M695.3M613.11M460.48M403.41M371.05M317.92M299.64M274.44M199.88M129.49M80.42M17.63M0158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
Revenue Growth %-7.36%-6.92%-5.62%44.08%74.38%-27.24%5.97%-0.24%13.4%33.15%14.15%8.72%16.71%6.1%9.18%37.3%54.36%61.02%356.25%--100%-10.28%18.41%9.36%-5.79%-4.37%-1.12%91.75%54.44%65.5%10.6%
Property Operating Expenses1.26B1.58B1.82B1.96B1.25B617.7M925.23M890.47M778.75M681.24M497.03M431.24M393.92M336.05M328.14M252.51M181.48M130.27M92.8M23.85M00000000000
Net Operating Income (NOI)-111.96M-396.46M-555.43M-618.09M-317.56M-82.88M-190.16M-196.84M-83.45M-68.13M-36.55M-27.84M-22.87M-18.13M-28.5M21.93M18.4M-783K-12.38M-6.22M0158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
NOI Margin %-9.74%-33.58%-43.79%-46%-34.05%-15.5%-25.87%-28.38%-12%-11.11%-7.94%-6.9%-6.16%-5.7%-9.51%7.99%9.21%-0.6%-15.4%-35.31%-100%100%100%100%100%100%100%100%100%100%
Operating Expenses-336.62M-491.4M-591.84M-667.89M-396.29M-168.56M-259.89M-246.67M-243.43M-206.58M-142.9M-123.23M-103.07M-93.92M-51.25M12.1M9.34M8.24M3.67M298K241.77K158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
G&A Expenses17.34M0000000000000000000016.09M13.69M11.82M22.66M10.11M8.74M7.3M11.1M3.8M2.2M
EBITDA766.64M658.9M711.56M780.51M531.81M288.39M373.56M340.22M439.61M383.44M283.21M249.53M220.63M195.29M139.17M117.37M86.41M44.57M21.34M3.27M-241.77K0000000000
EBITDA Margin %66.71%55.81%56.1%58.08%57.02%53.92%50.82%49.05%63.23%62.54%61.5%61.86%59.46%61.43%46.45%42.77%43.23%34.42%26.54%18.55%-0%0%0%0%0%0%0%0%0%0%
Depreciation & Amortization541.98M563.97M675.15M730.71M453.08M202.71M303.83M290.38M279.63M244.99M176.87M154.13M140.43M119.5M116.42M107.54M77.34M53.59M37.4M9.79M063.53M57.42M46.7M46.94M45.13M42.94M41.2M17.1M12.1M9M
D&A / Revenue %47.16%47.77%53.23%54.38%48.58%37.9%41.33%41.86%40.22%39.96%38.41%38.21%37.85%37.59%38.85%39.19%38.69%41.39%46.5%55.54%-40.02%32.45%31.25%34.35%31.11%28.31%26.86%21.38%23.36%28.75%
Operating Income224.66M94.94M36.41M49.81M78.73M85.68M69.73M49.84M159.98M138.45M106.34M95.4M80.2M75.79M22.75M9.83M9.07M-9.03M-16.06M-6.52M-241.77K0000000000
Operating Margin %19.55%8.04%2.87%3.71%8.44%16.02%9.49%7.18%23.01%22.58%23.09%23.65%21.62%23.84%7.59%3.58%4.54%-6.97%-19.97%-37%-0%0%0%0%0%0%0%0%0%0%
Interest Expense2M205.48M255.38M268.66M141.93M52.53M00101.56M84.27M56.77M58.11M57.49M52.26M45.33M39.61M35.34M29.35M21.34M5.02M047.98M43.25M34.64M34.27M38.11M42.99M38.6M13.1M8M7.3M
Interest Coverage--0.21x-1.60x-0.05x1.29x2.27x--3.14x1.78x1.91x1.58x1.80x1.45x0.46x1.14x0.73x0.16x-0.33x-0.53x--1.32x-1.33x-1.35x-1.37x-1.18x-1.00x-1.07x-1.31x-1.51x-1.23x
Non-Operating Income129.67M138.94M444.94M63.23M-103.9M-33.51M16.22M19.08M-159.21M-11.39M-1.81M3.73M-23.28M-42K1.8M-35.38M-16.85M-13.6M-8.99M-3.87M063.53M57.42M46.7M46.94M45.13M42.94M41.2M17.1M12.1M9M
Pretax Income-202.19M-249.49M-663.9M-282.08M40.69M66.66M53.51M30.76M217.63M65.58M51.38M33.56M45.99M23.58M-24.37M5.59M-9.41M-24.77M-28.41M-7.67M-241.77K0000000000
Pretax Margin %-17.6%-21.13%-52.35%-20.99%4.36%12.46%7.28%4.43%31.3%10.7%11.16%8.32%12.4%7.42%-8.13%2.04%-4.71%-19.13%-35.33%-43.54%-0%0%0%0%0%0%0%0%0%0%
Income Tax00000000000000000000048.97M43.9M34.6M34.2M38.11M42.99M38.6M13.1M8M7.3M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%----------
Net Income-201.25M-246.07M-654.49M-278.26M40.9M66.66M52.62M30.15M213.46M63.92M49.95M32.93M45.37M24.26M-24.42M5.54M-7.9M-25.08M-28.45M-7.67M-241.77K52.67M55.53M60.4M62.38M79.89M79.8M86M40.5M31.2M19.7M
Net Margin %-17.51%-20.84%-51.6%-20.71%4.39%12.46%7.16%4.35%30.7%10.42%10.85%8.16%12.23%7.63%-8.15%2.02%-3.95%-19.37%-35.38%-43.49%-33.17%31.38%40.42%45.65%55.08%52.61%56.06%50.63%60.23%62.94%
Net Income Growth %48.2%62.4%-135.21%-780.39%-38.65%26.68%74.5%-85.87%233.97%27.96%51.68%-27.42%87.01%199.33%-540.79%170.11%68.49%11.85%-271.09%-3070.77%-100.46%-5.16%-8.06%-3.18%-21.91%0.11%-7.21%112.35%29.81%58.38%7.65%
Funds From Operations (FFO)340.73M317.89M20.67M452.45M493.98M269.37M356.45M320.54M493.09M308.9M226.82M187.06M185.8M143.76M91.99M113.08M69.44M28.52M8.95M2.12M65.29M116.2M112.95M107.1M109.32M125.02M122.74M127.2M57.6M43.3M28.7M
FFO Margin %29.65%26.93%1.63%33.67%52.97%50.37%48.49%46.21%70.92%50.38%49.26%46.37%50.08%45.22%30.7%41.21%34.74%22.02%11.13%12.05%-73.19%63.83%71.67%80%86.19%80.92%82.92%72%83.59%91.69%
FFO Growth %66.73%1438.18%-95.43%-8.41%83.38%-24.43%11.2%-34.99%59.63%36.19%21.25%0.68%29.25%56.27%-18.65%62.86%143.48%218.64%321.37%-96.75%-43.81%2.87%5.46%-2.03%-12.56%1.86%-3.51%120.83%33.03%50.87%8.71%
FFO per Share0.980.910.061.191.951.891.611.532.351.671.621.461.531.250.831.010.840.510.420.4380502.132.452.522.562.633.083.053.202.352.332.17
FFO Payout Ratio %81.62%121.71%2215.38%104.37%284.9%65.14%45.6%48.47%30.47%46.08%58.09%64.29%62.63%77.61%104.74%78.94%109.2%320.45%908.39%4761.63%193.31%107.87%102.43%97.37%96.87%80.52%78.41%72.56%74.48%82.68%87.8%
EPS (Diluted)-0.58-0.71-1.81-0.740.150.450.240.141.020.350.330.260.370.21-0.220.04-0.10-0.44-1.32-1.54-298.061.111.241.441.371.671.821.991.631.681.49
EPS Growth %46.75%60.77%-144.59%-593.33%-66.67%87.5%71.43%-86.27%191.43%6.06%26.92%-29.73%76.19%195.45%-650%140%77.27%66.67%14.29%99.48%-26952.25%-10.48%-13.89%5.11%-17.96%-8.24%-8.54%22.09%-2.98%12.75%5.67%
EPS (Basic)--0.71-1.81-0.740.150.450.240.151.040.350.340.260.380.21-0.220.04-0.10-0.44-1.32-1.54-298.061.131.271.471.401.701.852.021.661.711.49
Diluted Shares Outstanding347.44M349.8M365.55M378.93M253.87M142.71M221.67M209.6M210.06M185.28M140.26M128M121.17M114.97M111.36M112.2M82.98M56.41M21.42M4.98M81147.45M44.78M41.84M41.49M40.61M40.3M39.81M24.52M18.57M13.25M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Integration and capital intensity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Contraction Amid Portfolio Integration

As reported in recent financial filings, Healthcare Realty Trust experienced a 10.5% year-over-year revenue decline in 2026Q1, signaling persistent headwinds in top-line growth following the large-scale HTA merger that appears to have complicated the company's ability to maintain its historical organic growth trajectory across the portfolio.

The consistent decline in revenue over the last ten quarters suggests that the integration of the HTA portfolio may be creating more friction than anticipated. Investors should monitor whether this contraction reflects a strategic shedding of non-core assets or a broader inability to drive rent growth within the existing medical office footprint.

Volatility in Core Earnings Metrics

Based on the company's reported figures, FFO per share has exhibited extreme volatility, swinging from a loss of $0.35 in 2024Q1 to a positive $0.37 in 2026Q1, which highlights significant instability in the REIT's ability to generate consistent cash flow for shareholders post-merger.

The erratic nature of FFO growth suggests that the company's earnings quality is currently compromised by non-recurring integration costs and potential accounting adjustments. Analysts should remain cautious regarding the sustainability of the dividend, as the wide variance in FFO makes it difficult to assess the true underlying cash-generating capacity.

Negative NOI Trends Warrant Scrutiny

According to the provided income statement data, the company reported negative Net Operating Income for seven consecutive quarters through 2025Q4, a highly unusual trend that suggests significant operational inefficiencies or aggressive accounting treatments that may be masking the true property-level profitability of the medical office assets.

While a return to positive NOI in 2026Q1 is a constructive development, the prolonged period of negative margins warrants deep investigation into the cost structure. It appears that the company is struggling to manage property-level expenses effectively, which may indicate that the scale benefits of the HTA merger have yet to materialize.

Distorted Earnings from Capital Intensity

Financial statements indicate that GAAP net income remains consistently negative, with a $56.0K loss in 2026Q1, illustrating how heavy depreciation charges and potential impairment costs continue to obscure the REIT's actual economic performance and cash-generating potential for long-term investors.

The persistent gap between GAAP net income and FFO suggests that the company's assets require substantial ongoing capital investment to remain competitive. This high level of recurring maintenance CAPEX appears to be a structural drag on AFFO, which may limit the company's financial flexibility in a higher interest rate environment.

HR — Frequently Asked Questions

Quick answers to the most common questions about buying HR stock.

What was Healthcare Realty Trust Incorporated's (HR) revenue in 2025?

For fiscal year 2025, Healthcare Realty Trust Incorporated (HR) reported total revenue of $1.18B. This represents a 3671.7% increase compared to $31.3M in 1996.

Is Healthcare Realty Trust Incorporated (HR) profitable?

Healthcare Realty Trust Incorporated (HR) reported a net loss of $246.1M for the fiscal year ending 2025.

What is Healthcare Realty Trust Incorporated's operating profit margin?

Healthcare Realty Trust Incorporated (HR) reported an operating income of $94.9M, resulting in an operating profit margin of 8.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Healthcare Realty Trust Incorporated's gross profit and gross margin?

Healthcare Realty Trust Incorporated (HR) generated $-396.5M in gross profit for the year, representing a gross profit margin of -33.6%. This demonstrates the company's core pricing power and production efficiency.